A genetic study in Drosophila gives important insights into the epigenetic control of gene expression implicated in a human mental retardation syndrome.
Epigenetic mechanisms that regulate gene expression are key processes in the interaction between genes and environmental inputs such as those received by the human brain via the sensory system. Epigenetic control of gene expression has been implicated in learning and memory, for example, and deregulation of epigenome plasticity seems to be an important step in the pathogenesis of neurological diseases [1] . As such, it is not surprising that recent studies investigating the genetic causes of mental retardation have found evidence for the involvement of the epigenetic machinery [2] .
Kleefstra syndrome (formally known as 9q34 syn drome) is a clinical condition comprising multiple features, includ ing severe mental retardation.
e syndrome is causally linked to mutations or disruption of the gene EHMT1 (euchromatic histone-lysine N-methyltransferase 1) [3] . EHMT1 (also known as G9a-like protein (GLP)) together with its homolog EHMT2 (G9a) is part of a histone-methyltransferase complex that specifically dimethylates histone 3 on lysine 9 (H3K9me2), a posttranslational histone modification generally associated with negative regulation of transcription (gene silencing). Although this modification can also be found in heterochromatin, EHMT1 and EHMT2 are responsible for selective H3K9 dimethylation in euchromatin [4] .
In a comprehensive study published recently in PLoS Biology, Annette Schenck and colleagues (Kramer et al. [5] ) identify the Drosophila melanogaster gene G9a as the sole Drosophila homolog of mammalian EHMT1 (GLA) and EHMT2 (G9a). Because of this, the authors have renamed Drosophila G9a as EHMT. Organism-wide deletion of this gene in Drosophila (by imprecise Pelement excision) is not lethal, and so the authors were able to analyze the cellular and behavioral characteristics of mutant larvae and adults and to correlate these with changes in genomic histone methylation.
Epigenetics and nervous system plasticity e plasticity of the nervous system -the capacity to modify the neuronal network in response to neuronal signaling -is essential to nervous system function. One essential determinant of neuronal plasticity is the complexity of organization of the dendritic tree -the set of branched processes through which a neuron mainly receives signals from other neurons. Kramer et al. [5] found that EHMT-mutant Drosophila larvae display sparser dendrite branching than wild-type larvae, as assessed in type-4 multidendrite neurons in the peripheral nervous system. ese neurons are involved in larval locomotory behavior and, accordingly, the mutant larvae displayed an altered crawling pattern. e dendritic-branching phenotype could be rescued by expression of wild-type EHMT in the type-4 neurons. However, wild-type EHMT expression did not reinstate normal larval locomotory behavior, suggesting that the deregulation of this behavior in the EHMT mutant is independent of the change in dendritic branching. e involvement of EHMT in dendritic plasticity is in line with the recent identification of a role for Ehmt2 in cocaine-induced dendritic plasticity in the mouse nucleus accumbens, which is a brain structure of the reward system and thereby implicated in addiction and emotional learning [6] .
Kramer et al. [5] also studied the role of EHMT in learning and memory in adult Drosophila. ey measured habituation learning using a light-off jump reflex habituation assay, and found that in EHMT mutants this form of non-associative memory function was impaired. Short-term and long-term courtship memory was also compromised in EHMT mutants, suggesting a role for EHMT in the consolidation or retrieval of new memories. Impairment of courtship memory could be rescued by pan-neuronal expression of wild-type EHMT under the control of the elav promoter, which restricts expression to neurons. More importantly, 7B-Gal4-driven expres sion of EHMT in the mushroom body only (a region of the Drosophila brain associated with learning and memory [7] ) was sufficient to reverse the mutant pheno type. As these promoters are already active during development of the nervous system, this type of approach does not rule out developmental effects of reintroduced EHMT expression. For that reason, the authors confirmed the reversibility of the observed memory impairments by inducing wildtype EHMT expression on only three consecutive days during adulthood, thus ruling out a developmental effect. In line with this, it has previously been reported that adultforebrainspecific ablation of Ehmt2 and Ehmt1 in the mouse causes memory impair ment without obvious alterations in dendritic organiza tion and brain development [8] .
Genome-wide changes in histone methylation in EHMT mutants
As EHMT is a H3K9 histonemethyltransferase, one would expect its loss to lead to the simultaneous deregu lation of numerous genes. In mice, chromatin immuno precipitation followed by DNA sequencing (ChIPseq) has been used to detect epigenetic alterations in brain regionspecific geneexpression profiles that define genetic programs important for memory formation [9] . Using a similar approach, Kramer et al. identified genomic regions that show reduced H3K9me2 in EHMT mutant larvae. Downregulation of H3K9me2 was most prominent in the promoter regions (defined as the region ≤1 kb upstream of the transcription start site) and down stream of the poly(A) sites, which mark, respectively, the 5' and the 3' ends of genes. The crosscorrelation of these data with microarray analysis of expressed mRNAs allowed the authors to identify genes that are usually repressed by EHMTmediated H3K9 dimethylation. Path way analysis of these genes revealed a striking enrich ment of genes implicated in nervoussystem develop ment and in other pathways associated with learning and memory. The finding of depletion of H3K9me2 at the 3' ends of upregulated genes in addition to depletion at the promoter region underscores the significance of changes in chromatin modifications to all levels of transcriptional regulation. This is also revealed by other recent data on the genomewide distribution of several histone modi fi cations, which showed functional diversification in differ ent genomic regions. In addition to affecting transcrip tional initiation, several different histone modifications have been found to be involved in the regulation of transcriptional elongation, exonintron definition and the activity of transcriptional characters, for example [9, 10] .
In mice, in contrast to Drosophila, the EHMT1 and EHMT2 methyltransferases have been found to control the repression of nonneuronal genes after neural differ entiation, and therefore aid memory consolidation and retrieval in maintenance mode, rather than in rela tion to developmental plasticity [7] . This difference might reflect the different developmental stages analyzed (larvae versus adult mice); Kramer et al. emphasize that a signi ficant proportion of the genes found in the mouse study are conserved in Drosophila and show decreased levels of H3K9me2 in the EHMT mutants, which means that the set of EHMTtarget genes in the two species can be assumed to overlap, at least in part. From a different point of view, the apparently conflicting results might also reflect the fact that epigenetic regulators control transcriptional programs or networks, rather than specific target genes, and that these networks can differ to some extent even in closely related species.
As mentalretardation syndromes are usually diag nosed only after birth, the ability to reverse symptoms in the individual will be crucial in the eventual translation of experimental results into clinical applications. The findings of Kramer et al. [5] , showing that some effects of EHMT loss are reversible, could point to a general feature of genetic diseases caused by disruption of the epigenetic machinery. As this machinery regulates geneenviron ment interaction, it may be a suitable and easily accessible interface for clinical intervention. Further investigation of the network of H3K9 dimethylation to identify other specific methyltransferases and/or antagonizing de methyl ases, as well as key target genes and alternative players in epigenetic gene regulation, could result in additional therapeutic possibilities, and will also give important insight into the general mechanisms under lying the more common 'sporadic' diseases of the nervous system those that have no readily discernable genetic basis.
